De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Schizophrenia likely results from poorly understood genetic and environmental factors. We studied the gene encoding the synaptic protein SHANK3 in 285 controls and 185 schizophrenia patients with unaffected parents. Two de novo mutations (R1117X and R536W) were identified in two families, one being found in three affected brothers, suggesting germline mosaicism. Zebrafish and rat hippocampal neuron assays revealed behavior and differentiation defects resulting from the R1117X mutant. As mutations in SHANK3 were previously reported in autism, the occurrence of SHANK3 mutations in subjects with a schizophrenia phenotype suggests a molecular genetic link between these two neurodevelopmental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SHANK3 mutations have also been identified in individuals developing adult-onset SHANK3 related-disorders, such as schizophrenia and bipolar disorders 96,97”
From Progress toward treatments for synaptic defects in autism (2013) · cites this paper as [97]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Functional studies have confirmed that this mutation causes a loss of SHANK3 function in zebrafish and decreases neurite outgrowth in mice.50”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [50]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the case of schizophrenia, the de novo mutation R1117X with germline mosaicism has been observed in three affected brothers.”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [50]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, point mutations, including a nonsense mutation in exon 21 (p.R1117X) of SHANK3 have been reported in families with schizophrenia and mild intellectual disability (Gauthier et al., 2010).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Gauthier et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SHANK3 mutations have been identified in patients suffering from schizophrenia and bipolar disorder [45], [47].”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [47]
Experimental — accuracy not yet measured
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SIFT: predicting amino acid changes that affect protein function
Ng, P. C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg509 · Cited by 6,577 · cited 3×
“Bromberg Y, Rost B (2007) SNAP: Predict effect of non-synonymous polymorphisms on function.”
BackgroundAdaptive protein evolution at the Adh locus in Drosophila
McDonald, J. H., & Kreitman, M. (1991) · Nature · doi:10.1038/351652a0 · Cited by 3,283 · cited 2×
“To evaluate whether SHANK3 is accumulating deleterious mutations in human populations, we performed a standard population genetic test (14) which asks whether there is an excess of potentially disruptive amino acid mutations accumulating at this locus more so than expected by chance (Table S4).”
BackgroundHuman non-synonymous SNPs: server and survey
Ramensky, V. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf493 · Cited by 2,280
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Large recurrent microdeletions associated with schizophrenia.
GROUP, Stefansson, H., Rujescu, D., Cichon, S., Pietiläinen, O. P. H., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., et al. (2008) · Nature · doi:10.1038/nature07229 · Cited by 1,745 · cited 1×
“Interestingly, recent studies reported de novo copy-number variants in SCZ, providing further support for the de novo mutation hypothesis (5, 6).”
ResultDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602 · cited 3×
“Deleterious SHANK3 mutations have previously been reported in ASD (7, 8, 32), suggesting that the phenotypic spectrum of such mutations is rather broad.”
BackgroundAutism screening questionnaire: diagnostic validity
Berument, S. K., Rutter, M., Lord, C., Pickles, A., & Bailey, A. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.5.444 · Cited by 1,464 · cited 1×
“To exclude a possible diagnosis of autism, the Autism Screening Questionnaire (10) was completed and her score was 1 (score> 15= autism).”
BackgroundMapping autism risk loci using genetic linkage and chromosomal rearrangements
The Autism Genome Project Consortium (2007) · Nature Genetics · doi:10.1038/ng1985 · Cited by 1,402
Prediction of deleterious human alleles
Sunyaev, S. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.591 · Cited by 1,044
SNAP: predict effect of non-synonymous polymorphisms on function
Bromberg, Y., & Rost, B. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm238 · Cited by 863
Research works printed but not linked: 1
- Goslin K, Asmussen H, Banker G. Rat hippocampal neurons in low-density culture. In: Banker G, Goslin K, editors. Culturing Nerve Cells. Cambridge, MA: MIT Press; 1998. [Google Scholar]
Cited by
De novo mutations in human genetic disease
Veltman, J. A., & Brunner, H. G. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3241 · Cited by 843
Autism risk factors: genes, environment, and gene-environment interactions
Chaste, P., & Leboyer, M. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.3/pchaste · Cited by 807
Zoghbi, H. Y., & Bear, M. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009886 · Cited by 797
“Recently, de novo mutations in SHANK3 were identified in patients with schizophrenia (Gauthier et al. 2010).”
BackgroundThe Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease
Berridge, M. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00006.2016 · Cited by 753
Leblond, C. S., Nava, C., Polge, A., Gauthier, J., Huguet, G., Lumbroso, S., Giuliano, F., Stordeur, C., Depienne, C., Mouzat, K., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004580 · Cited by 630
“(2009–2010) [16,47]]’’, 8 = ‘‘Moessner et al.”
BackgroundSelf-citationSHANK proteins: roles at the synapse and in autism spectrum disorder
Monteiro, P., & Feng, G. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.183 · Cited by 681
Bozdagi, O., Sakurai, T., Papapetrou, D., Wang, X., Dickstein, D. L., Takahashi, N., Kajiwara, Y., Yang, M., Katz, A. M., Scattoni, M. L., et al. (2010) · Molecular Autism · doi:10.1186/2040-2392-1-15 · Cited by 584
“Recently, de novo missense and nonsense mutations in SHANK3 have been described in atypical schizophrenia (with mild to moderate intellectual disability, early onset and dysmorphic features [29]).”
BackgroundVariation in genome-wide mutation rates within and between human families
the 1000 Genomes Project (2011) · Nature Genetics · doi:10.1038/ng.862 · Cited by 581
“Mutation underlies all heritable genetic variation, and the observation that a mutation has arisen de novo can be highly discriminating in identifying causal pathogenic variation in individual”
Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3
Wang, X., McCoy, P. A., Rodriguiz, R. M., Pan, Y., Je, H. S., Roberts, A. C., Kim, C. J., Berrios, J., Colvin, J. S., Bousquet-Moore, D., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr212 · Cited by 537
“For instance, point mutations or microdeletions of SHANK2 occur in cases of ASD and intellectual disability (49,50), whereas mutations in SHANK3 have been identified in individuals with schizophrenia (20,21).”
BackgroundModeling Autism by SHANK Gene Mutations in Mice
Jiang, Y.-H., & Ehlers, M. D. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.016 · Cited by 488
SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients
Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., Krawisz, A., Froehlich, W., Bernstein, J. A., Hallmayer, J. F., et al. (2013) · Nature · doi:10.1038/nature12618 · Cited by 470
Dendritic Spines: The Locus of Structural and Functional Plasticity
Sala, C., & Segal, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00012.2013 · Cited by 465
The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)
Phelan, K., & McDermid, H. E. (2011) · Molecular Syndromology · doi:10.1159/000334260 · Cited by 460
“In mice this gene is expressed in the brain, and the protein is enriched in PSDs [Giza et al., 2010].”
BackgroundNew insights into the generation and role of de novo mutations in health and disease
Acuna-Hidalgo, R., Veltman, J. A., & Hoischen, A. (2016) · Genome Biology · doi:10.1186/s13059-016-1110-1 · Cited by 453
The Genetic Landscapes of Autism Spectrum Disorders
Huguet, G., Ey, E., & Bourgeron, T. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153431 · Cited by 450
Leblond, C. S., Heinrich, J., Delorme, R., Proepper, C., Betancur, C., Huguet, G., Konyukh, M., Chaste, P., Ey, E., Rastam, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002521 · Cited by 429
“Deletions of ProSAP2/SHANK3 at chromosome 22q13 are one of the major genetic abnormalities in neurodevelopmental disorders [20], and mutations of ProSAP2/ SHANK3 have been identified in patients with ASD, intellectual disability (ID) and schizophrenia [7,23–25].”
Genetic and Epigenetic Networks in Intellectual Disabilities
van Bokhoven, H. (2011) · Annual Review of Genetics · doi:10.1146/annurev-genet-110410-132512 · Cited by 382
SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties
Han, K., Holder Jr, J. L., Schaaf, C. P., Lu, H., Chen, H., Kang, H., Tang, J., Wu, Z., Hao, S., Cheung, S. W., et al. (2013) · Nature · doi:10.1038/nature12630 · Cited by 353
“Disruption of the ProSAP2 gene in a t(12;22)(q24.”
BackgroundHamdan, F. F., Gauthier, J., Araki, Y., Lin, D.-T., Yoshizawa, Y., Higashi, K., Park, A.-R., Spiegelman, D., Dobrzeniecka, S., Piton, A., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.02.001 · Cited by 349
Self-citationKey role for gene dosage and synaptic homeostasis in autism spectrum disorders
Toro, R., Konyukh, M., Delorme, R., Leblond, C., Chaste, P., Fauchereau, F., Coleman, M., Leboyer, M., Gillberg, C., & Bourgeron, T. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.05.007 · Cited by 331
Zhou, Y., Kaiser, T., Monteiro, P., Zhang, X., Van der Goes, M. S., Wang, D., Barak, B., Zeng, M., Li, C., Lu, C., et al. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.023 · Cited by 325
“Given the fact that patients carrying the schizophrenia-associated R1117X Shank3 mutation were diagnosed at their late adolescence stage (Gauthier et al., 2010), we examined whether there are synaptic defects in the mPFC of young mice (P14) from either mutant line.”
BackgroundSHANK1 Deletions in Males with Autism Spectrum Disorder
Sato, D., Lionel, A. C., Leblond, C. S., Prasad, A., Pinto, D., Walker, S., O'Connor, I., Russell, C., Drmic, I. E., Hamdan, F. F., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.017 · Cited by 318
Self-citationDurand, C. M., Perroy, J., Loll, F., Perrais, D., Fagni, L., Bourgeron, T., Montcouquiol, M., & Sans, N. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.57 · Cited by 316
Autism-associated SHANK3 haploinsufficiency causes I h channelopathy in human neurons
Yi, F., Danko, T., Botelho, S. C., Patzke, C., Pak, C., Wernig, M., & Südhof, T. C. (2016) · Science · doi:10.1126/science.aaf2669 · Cited by 313
“In addition, emerging evidence links SHANK3 mutations to schizophrenia (6, 7), and SHANK3 overexpression has also been implicated in neuropsychiatric disorders (8).”
BackgroundKouser, M., Speed, H. E., Dewey, C. M., Reimers, J. M., Widman, A. J., Gupta, N., Liu, S., Jaramillo, T. C., Bangash, M., Xiao, B., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3017-13.2013 · Cited by 288
“Shank3 mutant mice exhibit normal startle response and PPI SHANK3 and other autism genes are implicated in schizophrenia (Burbach and van der Zwaag, 2009; Gauthier et al., 2009, 2010; Verpelli et al., 2012).”
BackgroundTruncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia
Gauthier, J., Siddiqui, T. J., Huashan, P., Yokomaku, D., Hamdan, F. F., Champagne, N., Lapointe, M., Spiegelman, D., Noreau, A., Lafrenière, R. G., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-0975-z · Cited by 286
Self-citationThe Dynamics of DNA Methylation in Schizophrenia and Related Psychiatric Disorders
Grayson, D. R., & Guidotti, A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.125 · Cited by 267
Unlocking Mendelian disease using exome sequencing
Gilissen, C., Hoischen, A., Brunner, H. G., & Veltman, J. A. (2011) · Genome Biology · doi:10.1186/gb-2011-12-9-228 · Cited by 266
Is schizophrenia on the autism spectrum?
King, B. H., & Lord, C. (2011) · Brain Research · doi:10.1016/j.brainres.2010.11.031 · Cited by 255
Atypical behaviour and connectivity in SHANK3-mutant macaques
Zhou, Y., Sharma, J., Ke, Q., Landman, R., Yuan, J., Chen, H., Hayden, D. S., Fisher, J. W., Jiang, M., Menegas, W., et al. (2019) · Nature · doi:10.1038/s41586-019-1278-0 · Cited by 251
Glutamate Synapses in Human Cognitive Disorders
Volk, L., Chiu, S.-L., Sharma, K., & Huganir, R. L. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-033821 · Cited by 248
Persico, A. M., & Napolioni, V. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.06.012 · Cited by 238
“wo de novo mutations, R536W and R1117X, never reported in SD patients, were detected in individuals with schizophrenia [78].”
BackgroundPrevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders
Boccuto, L., Lauri, M., Sarasua, S. M., Skinner, C. D., Buccella, D., Dwivedi, A., Orteschi, D., Collins, J. S., Zollino, M., Visconti, P., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.175 · Cited by 240
Direct Measure of the De Novo Mutation Rate in Autism and Schizophrenia Cohorts
Awadalla, P., Gauthier, J., Myers, R. A., Casals, F., Hamdan, F. F., Griffing, A. R., Côté, M., Henrion, E., Spiegelman, D., Tarabeux, J., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.07.019 · Cited by 239
Self-citationThe emerging role of SHANK genes in neuropsychiatric disorders
Guilmatre, A., Huguet, G., Delorme, R., & Bourgeron, T. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22128 · Cited by 237
“sequenced the coding regions of SHANK3 in 185 patients with schizophrenia (Gauthier et al., 2010).”
BackgroundDe Novo Mutations in FOXP1 in Cases with Intellectual Disability, Autism, and Language Impairment
Hamdan, F. F., Daoud, H., Rochefort, D., Piton, A., Gauthier, J., Langlois, M., Foomani, G., Dobrzeniecka, S., Krebs, M.-O., Joober, R., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.09.017 · Cited by 235
Self-citationPostsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies
Grabrucker, A. M., Schmeisser, M. J., Schoen, M., & Boeckers, T. M. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.07.003 · Cited by 233
Glutamatergic model psychoses: prediction error, learning, and inference
Corlett, P. R., Honey, G. D., Krystal, J. H., & Fletcher, P. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.163 · Cited by 229
An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
Tarabeux, J., Kebir, O., Gauthier, J., Hamdan, F. F., Xiong, L., Piton, A., Spiegelman, D., Henrion, É., Millet, B., S2D team, et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.52 · Cited by 231
“unlinked microsatellite markers as described in Gauthier et al.(46)”
BackgroundSelf-citationConcerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation
Grabrucker, A. M., Knight, M. J., Proepper, C., Bockmann, J., Joubert, M., Rowan, M., Nienhaus, G. U., Garner, C. C., Bowie, J. U., Kreutz, M. R., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.336 · Cited by 228
Bonaglia, M. C., Giorda, R., Beri, S., De Agostini, C., Novara, F., Fichera, M., Grillo, L., Galesi, O., Vetro, A., Ciccone, R., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002173 · Cited by 224
“Mutations in SHANK3 have also been found in schizophrenia [22] and nonsyndromic intellectual disability [23].”
BackgroundProgress toward treatments for synaptic defects in autism
Delorme, R., Ey, E., Toro, R., Leboyer, M., Gillberg, C., & Bourgeron, T. (2013) · Nature Medicine · doi:10.1038/nm.3193 · Cited by 218
Fernandez, T. V., Sanders, S. J., Yurkiewicz, I. R., Ercan-Sencicek, A. G., Kim, Y.-S., Fishman, D. O., Raubeson, M. J., Song, Y., Yasuno, K., Ho, W. S. C., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.034 · Cited by 208
De Rubeis, S., Siper, P. M., Durkin, A., Weissman, J., Muratet, F., Halpern, D., Trelles, M. D. P., Frank, Y., Lozano, R., Wang, A. T., et al. (2018) · Molecular Autism · doi:10.1186/s13229-018-0205-9 · Cited by 199
“Mutations in SHANK3 have also been found in four individuals from two families with atypical schizophrenia associated with early onset and ID [22].”
BackgroundInfluentialDe Novo SYNGAP1 Mutations in Nonsyndromic Intellectual Disability and Autism
Hamdan, F. F., Daoud, H., Piton, A., Gauthier, J., Dobrzeniecka, S., Krebs, M.-O., Joober, R., Lacaille, J.-C., Nadeau, A., Milunsky, J. M., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.11.015 · Cited by 187
Self-citationCalcium signalling and psychiatric disease: bipolar disorder and schizophrenia
Berridge, M. J. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1806-z · Cited by 181
“Alterations in mGluR5 may contribute to schizophrenia (Matosin and Newell 2013) and mutations in SHANK have been linked to various neuropsychiatric diseases including schizophrenia (Gauthier et al. 2010; Guilmatre et al. 2014).”
BackgroundPotential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
Krystal, J. H., Mathew, S. J., DʼSouza, D. C., Garakani, A., Gunduz-Bruce, H., & Charney, D. S. (2010) · CNS Drugs · doi:10.2165/11533230-000000000-00000 · Cited by 180
Behavioral phenotypes of genetic mouse models of autism
Kazdoba, T. M., Leach, P. T., & Crawley, J. N. (2016) · Genes, Brain and Behavior · doi:10.1111/gbb.12256 · Cited by 178
“Genetic studies have identified de novo and inherited mutations in SHANK1 (Sato et al. 2012), SHANK2 (Berkel et al. 2010, 2012; Pinto et al. 2010) and SHANK3 (Boccuto et al. 2013; Durand et al. 2007; Gauthier et al. 2009, 2010; Marshall et al. 2008; Moessner et al. 2007).”
BackgroundSHANK3 as an autism spectrum disorder-associated gene
Uchino, S., & Waga, C. (2013) · Brain and Development · doi:10.1016/j.braindev.2012.05.013 · Cited by 176
“Furthermore, recent genetic studies have identified SHANK3 mutations in patients with schizophrenia, a chronic psychiatric disorder characterized by disabilities in cognition, behavior and emotion [19,20], suggesting that SHANK3 mutations are probably associated with psychiatric disorders in addition to neurodevelopme…”
BackgroundSala, C., Vicidomini, C., Bigi, I., Mossa, A., & Verpelli, C. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13232 · Cited by 175
Wang, X., Xu, Q., Bey, A. L., Lee, Y., & Jiang, Y.-H. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-30 · Cited by 169
The genetics of neurodevelopmental disease
Mitchell, K. J. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.08.009 · Cited by 164
Lionel, A. C., Vaags, A. K., Sato, D., Gazzellone, M. J., Mitchell, E. B., Chen, H. Y., Costain, G., Walker, S., Egger, G., Thiruvahindrapuram, B., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt056 · Cited by 162
“2 as well as at individual genes such as CNTNAP2, NRXN1 and SHANK3 (21,29,84,85).”
BackgroundZebrafish Models of Neurodevelopmental Disorders: Past, Present, and Future
Sakai, C., Ijaz, S., & Hoffman, E. J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00294 · Cited by 160
“…of novel genes and rare variants identified in human genetics studies of epilepsy, ID and other neurodevelopmental disorders (Table 3, Bassuk et al., 2008; Gauthier et al., 2010; Suls et al., 2013; Schubert et al., 2014; Kury et al., 2017; Reijnders et al., 2017; MarinValencia et al., 2018).”
BackgroundMethodThe genetics of child psychiatric disorders: focus on autism and Tourette syndrome
State, M. W. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.004 · Cited by 162
“…with schizophrenia (Weiss et al., 2008), a finding that has been solidly supported by a large case control association analysis (McCarthy et al., 2009) and de novo mutations in SHANK3 have been identified in individuals with schizophrenia as well as those with ASD (Gauthier et al., 2010).”
ResultBerkel, S., Tang, W., Treviño, M., Vogt, M., Obenhaus, H. A., Gass, P., Scherer, S. W., Sprengel, R., Schratt, G., & Rappold, G. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr470 · Cited by 162
“Although SHANK3 mutations have been shown to cause ASD, ID and schizophrenia (21,22), Shank1 has not been associated with any disease phenotype yet.”
Behavioral profiles of mouse models for autism spectrum disorders
Ey, E., Leblond, C. S., & Bourgeron, T. (2011) · Autism Research · doi:10.1002/aur.175 · Cited by 161
Fernandez, B. A., & Scherer, S. W. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.4/sscherer · Cited by 158
CRISPR/Cas9-induced shank3b mutant zebrafish display autism-like behaviors
Liu, C.-X., Li, C.-Y., Hu, C.-C., Wang, Y., Lin, J., Jiang, Y.-H., Li, Q., & Xu, X. (2018) · Molecular Autism · doi:10.1186/s13229-018-0204-x · Cited by 158
Developing zebrafish models of autism spectrum disorder (ASD)
Stewart, A., Nguyen, M., Wong, K., Poudel, M. K., & Kalueff, A. V. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.11.014 · Cited by 175
“The fact that this gene is strongly implicated in CNS function in zebrafish, rodents and humans (Gauthier et al., 2010) strongly supports the value of zebrafish models to study CNS pathogenesis, including ASD.”
InfluentialZebrafish models of autism spectrum disorder
Мешалкина, Д. А., Kizlyk, M. N., Kysil, E. V., Collier, A. D., Echevarria, D. J., de Abreu, M. S., Barcellos, L. J. G., Song, C., Warnick, J. E., Kyzar, E. J., et al. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.02.004 · Cited by 180
Jaramillo, T. C., Speed, H. E., Xuan, Z., Reimers, J. M., Liu, S., & Powell, C. M. (2016) · Autism Research · doi:10.1002/aur.1529 · Cited by 153
“…or rearrangements involving SHANK3 have been observed in genetic studies involving ASD patients [Bonaglia et al., 2001, 2006; Durand et al., 2007; Gauthier et al., 2009, 2010; Grabrucker, Schmeisser, Schoen, & Boeckers, 2011; Hamdan et al., 2011; Jiang & Ehlers, 2013; Kolevzon et al., 2011;…”
BackgroundCLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency
Bidinosti, M., Botta, P., Krüttner, S., Proenca, C. C., Stoehr, N., Bernhard, M., Fruh, I., Mueller, M., Bonenfant, D., Voshol, H., et al. (2016) · Science · doi:10.1126/science.aad5487 · Cited by 151
Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders
Zhu, L., Wang, X., Li, X.-L., Towers, A., Cao, X., Wang, P., Bowman, R., Yang, H., Goldstein, J., Li, Y.-J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt547 · Cited by 147
“Furthermore, small microdeletions, de novo missense and frame-shift mutations in SHANK3 have been identified in ASD cases (18–20) as well as in families with schizophrenia and mild intellectual disability (21).”
Lee, J., Chung, C., Ha, S., Lee, D., Kim, D.-Y., Kim, H., & Kim, E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00094 · Cited by 147
“…(ASDs), Phelan-McDermid syndrome, schizophrenia, and intellectual disability (Bonaglia et al., 2001, 2011; Durand et al., 2007; Moessner et al., 2007; Berkel et al., 2010; Gauthier et al., 2010; Hamdan et al., 2011; Leblond et al., 2012, 2014; Boccuto et al., 2013; Guilmatre et al., 2014).”
BackgroundVaz, R., Hofmeister, W., & Lindstrand, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061296 · Cited by 166
“Stable mutant studies: swimming behavior and visual motor response test showed a decrease in response in larvae and adults; embryonic brain shows a decrease in the huc-positive cells, this difference becomes smaller throughout development [83,166,167]”
BackgroundMathur, P., & Guo, S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.016 · Cited by 155
“Knockdown of zSHANK3 orthologous genes in zebrafish produced behavioral and differentiation defects (Gauthier et al., 2010).”
SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras
Lilja, J., Zacharchenko, T., Georgiadou, M., Jacquemet, G., Franceschi, N. D., Peuhu, E., Hamidi, H., Pouwels, J., Martens, V., Nia, F. H., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3487 · Cited by 132
“Sparse matrix crystal screening of SHANK3 (1-348) was performed using an innovadyne nanodrop screen maker at protein concentration of 6mgml−1 with a 200 nl drop size (1:1 ratio) using sitting drop vapour diffusion.”
MethodSchizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss
Bennett, M. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.003 · Cited by 146
Toward developmental models of psychiatric disorders in zebrafish
Norton, W. H. J. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00079 · Cited by 127
“Gauthier et al. (2010) have used morpholinos to knockdown SHANK3, a gene linked to schizophrenia and ASD in human patients. shank3 morphant zebrafish show decreased swimming after being touched, a phenotype which can be rescued with a wild-type (but not a mutant) version of the corresponding rat…”
Backgroundde Bartolomeis, A., Latte, G., Tomasetti, C., & Iasevoli, F. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8534-3 · Cited by 137
“Notably, in all the above cases, mental retardation was also diagnosed [103].”
BackgroundInfluentialRisk factors for autism: translating genomic discoveries into diagnostics
Scherer, S. W., & Dawson, G. (2011) · Human Genetics · doi:10.1007/s00439-011-1037-2 · Cited by 144
“Recently, point mutations were found in the same gene in two individuals with schizophrenia (Gauthier et al. 2010) and in the related SHANK2 gene in individuals with intellectual disability and ASD (Berkel et al. 2010).”
BackgroundMerner, N. D., Chandler, M. R., Bourassa, C. V., Liang, B., Khanna, A. R., Dion, P. A., Rouleau, G. A., & Kahle, K. T. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00386 · Cited by 143
“…in MECP2 [OMIM 300005] (Lam et al., 2000) and SLC6A8 [OMIM 300036] (Salomons et al., 2001) have been found in both ID and ASD; and, mutations in SHANK3 [OMIM 606230] have been identified in ASD (Durand et al., 2007), SCZ (Gauthier et al., 2010) and nonsyndromic ID cohorts (Hamdan et al., 2011).”
BackgroundSelf-citationDeletion of Glutamate Delta-1 Receptor in Mouse Leads to Aberrant Emotional and Social Behaviors
Yadav, R., Gupta, S. C., Hillman, B. G., Bhatt, J. M., Stairs, D. J., & Dravid, S. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032969 · Cited by 123
Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?
Gandal, M. J., Anderson, R. L., Billingslea, E. N., Carlson, G. C., Roberts, T. P. L., & Siegel, S. J. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2012.00816.x · Cited by 121
“Many genes originally linked to autism have been recently associated with schizophrenia, including NRXN1 and SHANK3 (Gauthier et al., 2010, Levinson et al., 2011).”
BackgroundJaramillo, T. C., Speed, H. E., Xuan, Z., Reimers, J. M., Escamilla, C. O., Weaver, T. P., Liu, S., Filonova, I., & Powell, C. M. (2017) · Autism Research · doi:10.1002/aur.1664 · Cited by 119
Santini, E., & Klann, E. (2014) · Science Signaling · doi:10.1126/scisignal.2005832 · Cited by 118
Zebrafish models for the functional genomics of neurogenetic disorders
Kabashi, E., Brustein, E., Champagne, N., & Drapeau, P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.011 · Cited by 141
Self-citationRETRACTED: Enhanced Polyubiquitination of Shank3 and NMDA Receptor in a Mouse Model of Autism
Bangash, M. A., Park, J. M., Melnikova, T., Wang, D., Jeon, S. K., Lee, D., Syeda, S., Kim, J., Kouser, M., Schwartz, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.052 · Cited by 114
RetractedTing, J. T., Peça, J., & Feng, G. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150442 · Cited by 108
“Finally, Shank3 has also been linked with a potential role in the development of schizophrenia (Gauthier et al. 2010).”
BackgroundWöhr, M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.021 · Cited by 107
Genetic basis of autism: is there a way forward?
Eapen, V. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328345927e · Cited by 102
Homann, O. R., Misura, K., Lamas, E., Sandrock, R. W., Nelson, P., McDonough, S. I., & DeLisi, L. E. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.24 · Cited by 104
Self-citationKu, C., Polychronakos, C., Tan, E., Naidoo, N., Pawitan, Y., Roukos, D. H., Mort, M. E., & Cooper, D. N. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.58 · Cited by 104
Chilian, B., Abdollahpour, H., Bierhals, T., Haltrich, I., Fekete, G., Nagel, I., Rosenberger, G., & Kutsche, K. (2013) · Clinical Genetics · doi:10.1111/cge.12105 · Cited by 85
A Bayesian framework for de novo mutation calling in parents-offspring trios
Wei, Q., Zhan, X., Zhong, X., Liu, Y., Han, Y., Chen, W., & Li, B. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu839 · Cited by 97
Shams, S., Rihel, J., Ortíz, J. G., & Gerlai, R. T. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.002 · Cited by 108
“, 2009), knockdowns of either zebrafish shank1a, shank1b, or syngap1b delayed brain development and caused seizures and altered motility (Gauthier et al., 2010; Kozol et al., 2015), and MOs targeting autism susceptibility candidate 2 (auts2) led to reduced head size and loss of neurons (Oksenberg et al.”
BackgroundBrue, T., Quentien, M.-H., Khetchoumian, K., Bensa, M., Capo-Chichi, J.-M., Delemer, B., Balsalobre, A., Nassif, C., Papadimitriou, D. T., Pagnier, A., et al. (2014) · BMC Medical Genetics · doi:10.1186/s12881-014-0139-9 · Cited by 95
Self-citationLi, H., Zhu, Y., Morozov, Y. M., Chen, X., Page, S. C., Rannals, M. D., Maher, B. J., & RAKIC, P. T. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0353-0 · Cited by 107
Identification and functional characterization of rare SHANK2 variants in schizophrenia
Peykov, S., Berkel, S., Schoen, M., Weiss, K., Degenhardt, F., Strohmaier, J., Weiss, B., Proepper, C., Schratt, G., Nöthen, M. M., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.172 · Cited by 93
Delling, J. P., & Boeckers, T. M. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09397-8 · Cited by 109
Scaffold Proteins at the Postsynaptic Density
Verpelli, C., Schmeisser, M. J., Sala, C., & Boeckers, T. M. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_2 · Cited by 92
“Interestingly, all three ProSAP/Shank family members show a distinct expression pattern in Xenopus laevis embryos indicating a functional role of this protein family not only in the adult organism but also in embryonic development (Gessert et al. 2011).”
BackgroundFreudenberg, F., Celikel, T., & Reif, A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.03.005 · Cited by 105
Kerr, J. M., & Blanpied, T. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2927-11.2012 · Cited by 91
“Given this, our model suggests disease-associated perturbations of the spine actin cytoskeleton or PSD (Bonaglia et al., 2001; Durand et al., 2007; Gauthier et al., 2010) may induce pathological disruption of synapse function even without overt loss of spines, through altered cytoskeletal control…”
MethodPsychiatric illness and regression in individuals with Phelan-McDermid syndrome
Kohlenberg, T. M., Trelles, M. P., McLarney, B., Betancur, C., Thurm, A. E., & Kolevzon, A. (2020) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-020-9309-6 · Cited by 99
“(2010) identified sequence variants in the SHANK3 gene in four individuals initially diagnosed with atypical, early-onset schizophrenia, and a history of borderline to mild intellectual disability [21].”
BackgroundEmerging evidence for astrocyte dysfunction in schizophrenia
Figueiredo, E. C. D. O., Calì, C., Petrelli, F., & Bezzi, P. (2022) · Glia · doi:10.1002/glia.24221 · Cited by 92
“…histological evidence indicates that a hallmark of SCZ path- ophysiology is widespread synaptic dysfunction and loss, also known as synaptopathy (Adams et al., 2022; Berkel et al., 2010; Gauthier et al., 2010; Glessner et al., 2010; Hall & Bray, 2021; Osimo et al., 2019; Trubetskoy et al., 2022).”
BackgroundKozol, R. A., Cukier, H. N., Zou, B., Mayo, V., De Rubeis, S., Cai, G., Griswold, A. J., Whitehead, P. L., Haines, J. L., Gilbert, J. R., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv138 · Cited by 86
Cochoy, D. M., Kolevzon, A., Kajiwara, Y., Schoen, M., Pascual‐Lucas, M., Lurie, S., Buxbaum, J. D., Boeckers, T. M., & Schmeißer, M. J. (2015) · Molecular Autism · doi:10.1186/s13229-015-0020-5 · Cited by 98
“However, the three stop mutations studied to date all affect exon 21 of SHANK3, but less is known about mutations identified in ASD and/or ID that affect other parts of the gene [15-17,19-22].”
BackgroundInfluentialUsing Zebrafish to Unravel the Genetics of Complex Brain Disorders
Gerlai, R. T. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_180 · Cited by 96
“Morpholino-induced knock down of the expression of the corresponding gene resulted in robust morphological abnormalities as well as impaired swimming in response to tactile stimulation in the zebrafish larva (Gauthier et al. 2010).”
Background
Metadata
- Authors
- Gauthier, J., Champagne, N., Lafrenière, R. G., Xiong, L., Spiegelman, D., Brustein, E., Lapointe, M., Peng, H., Côté, M., Noreau, A., Hamdan, F. F., Addington, A. M., Rapoport, J. L., DeLisi, L. E., Krebs, M.-O., Joober, R., Fathalli, F., Mouaffak, F., Haghighi, A. P., Néri, C., Dubé, M.-P., Samuels, M. E., Marineau, C., Stone, E. A., Awadalla, P., Barker, P. A., Carbonetto, S., Drapeau, P., Rouleau, G. A., the S2D Team, Daignault, K., Diallo, O., Duguay, J., Drits, M., Henrion, E., Jolivet, P., Kuku, F., Lachapelle, K., Laliberté, G., Laurent, S., Liao, M., Marino, C., Piton, A., Raymond, A., Reynolds, A., Rochefort, D., St-Onge, J., Thibodeau, P., Tsurudome, K., Yang, Y., Leroy, S., Ossian, K., Chayet, M., & Gourion, D.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Université de Montréal (CA)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD 20892-1600;
- National Institute of Mental Health (US)
- Harvard University (US)
- Centre Hospitalier Sainte-Anne (FR)
- Douglas Mental Health University Institute (CA)
- McGill University (CA)
- Inserm (FR)
- Montreal Heart Institute (CA)
- North Carolina State University (US)
- Montreal Neurological Institute and Hospital (CA)
- Montreal General Hospital (CA)
- ORCID
- Xiong, Lan
- Spiegelman, Dan
- Hamdan, Fadi F.
- DeLisi, Lynn E.
- Krebs, Marie-Odile
- Joober, Ridha
- Mouaffak, Fayçal
- Haghighi, Ali P.
- Néri, Christian
- Dubé, Marie-Pierre
- Samuels, Mark E.
- Stone, Eric A.
- Awadalla, Philip
- Barker, Philip A.
- Drapeau, Pierre
- Rouleau, Guy A.
- Jolivet, Philippe
- Liao, Meijiang
- Piton, Amélie
- Rochefort, Daniel
- Leroy, Sophie
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-04-12
- Volume
- 107
- Issue
- 17
- Pages
- 7863-7868
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2867875
- OpenAlex
- W1978075999
- Cited by
- 369
- References
- 41
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 19 · 2023: 20 · 2022: 9 · 2021: 19 · 2020: 21 · 2019: 17 · 2018: 25 · 2017: 24 · 2016: 22 · 2015: 38 · 2014: 22 · 2013: 29 · 2012: 40
- FWCI
- 22.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Genome Canada
- Génome Québec
- Université de Montréal
- Fondation Pierre Deniker pour la Recherche et la Prévention en Santé Mentale
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- schizophrenia, SHANK3, de novo mutations, germline mosaicism, synaptic scaffolding proteins, neurodevelopmental disorders, autism spectrum disorder, hippocampal neurons, zebrafish, rats, behavioral defects, neuronal differentiation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Carrier Proteins, Female, Humans, Male, Molecular Sequence Data, Nerve Tissue Proteins, Neurons, Pedigree, Schizophrenia, Zebrafish, Sequence Analysis, DNA, DNA Primers, Microsatellite Repeats, Computational Biology, Mutation, Missense, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.